The present invention relates generally to implantable intraluminal devices, particularly intraluminal grafts. Intraluminal stents are implanted in order to maintain luminal patency, typically after interventional methods have been employed to restore luminal patency from a diseased state, exclude an aneurysmal condition, bypass an occluded or obstructed anatomical region or to shunt body fluids. Surgically implantable prosthetics, particularly vascular prostheses, have been employed for many years. Expanded polytetrafluoroethylene (ePTFE) vascular grafts have been used as biocompatible implants for many years and the use of ePTFE as a bio-inert barrier material in intraluminal applications is well documented. Conventional ePTFE vascular grafts, however, typically lack sufficient diametric mechanical rigidity to maintain luminal patency in intraluminal applications.
Conventional externally supported ePTFE vascular grafts, such as the IMPRA Flex-Graft or the Gore Ring Graft, have an external beading of helically wound non-expanded or solid polytetrafluoroethylene, or of solid fluorinated ethylene-propylene co-polymer (FEP). Non-expanded or solid polytetrafluoroethylene is significantly more rigid than the ePTFE material due to its higher density and absence of interstitial voids. These externally supported ePTFE vascular grafts are not well-suited to interventional intraluminal procedures due to their inability to assume a reduced profile suitable for percutaneous delivery using a catheter and their inability to recover an enlarged diametric dimension in vivo.
Most intraluminal stents are formed of an open lattice fashioned either to be elastically deformable, such as in the case of self-expanding stainless steel spring stents, plastically deformable, such as in the case of balloon-expandable stainless steel PALMAZ stents, or thermally expandable such as by employing shape memory properties of the material used to form the stent. A common problem of most conventional intraluminal stents is re-occlusion of the vessel after stent placement. Tissue ingrowth and neointimal hyperplasia significantly reduces the open diameter of the treated lumen over time, requiring additional therapies.
The present invention makes advantageous use of the known biocompatible and material properties of ePTFE vascular grafts, and adds an abluminal supporting structure capable of being diametrically reduced to an intraluminal delivery profile and self-expanding in vivo to conform to the anatomical topography at the site of intraluminal implantation. More particularly, the present invention consists of an ePTFE substrate material, such as that described in U.S. application Ser. No. 08/794,871, filed Feb. 5, 1997, now U.S. Pat. No. 6,039,755, as a carrier for a helically wound, open cylindrical support structure made of a shape memory alloy.
The inventive intraluminal stent-graft device may be implanted either by percutaneous delivery using an appropriate delivery system, a cut-down procedure in which a surgical incision is made and the intraluminal device implanted through the surgical incision, or by laparoscopic or endoscopic delivery.
Shape memory alloys are a group of metal alloys which are characterized by an ability to return to a defined shape or size when subjected to certain thermal or stress conditions. Shape memory alloys are generally capable of being plastically deformed at a relatively low temperature and, upon exposure to a relatively higher temperature, return to the defined shape or size prior to the deformation. Shape memory alloys may be further defined as one that yields a thermoelastic martensite. A shape memory alloy which yields a thermoelastic martensite undergoes a martensitic transformation of a type that permits the alloy to be deformed by a twinning mechanism below the martensitic transformation temperature. The deformation is then reversed when the twinned structure reverts upon heating to the parent austenite phase. The austenite phase occurs when the material is at a low strain state and occurs at a given temperature. The martensite phase may be either temperature induced martensite (TIM) or stress-induced martensite (SIM).
When a shape memory material is stressed at a temperature above the start of martensite formation, denoted Ms, where the austenitic state is initially stable, but below the maximum temperature at which martensite formation can occur, denoted Md, the material first deforms elastically and when a critical stress is reached, it begins to transform by the formation of stress-induced martensite. Depending upon whether the temperature is above or below the start of austenite formation, denoted As, the behavior when the deforming stress is released differs. If the temperature is below As, the stress-induced martensite is stable, however, if the temperature is above As, the martensite is unstable and transforms back to austenite, with the sample returning to its original shape. U.S. Pat. Nos. 5,597,378, 5,067,957 and 4,665,906 disclose devices, including endoluminal stents, which are delivered in the stress-induced martensite phase of shape memory alloy and return to their pre-programmed shape by removal of the stress and transformation from stress-induced martensite to austenite.
Shape memory characteristics may be imparted to a shape memory alloy by heating the metal at a temperature above which the transformation from the martensite phase to the austenite phase is complete, i.e., a temperature above which the austenite phase is stable. The shape imparted to the metal during this heat treatment is the shape “remembered.” The heat treated metal is cooled to a temperature at which the martensite phase is stable, causing the austenite phase to transform to the martensite phase. The metal in the martensite phase is then plastically deformed, e.g., to facilitate its delivery into a patient's body. Subsequent heating of the deformed martensite phase to a temperature above the martensite to austenite transformation temperature, e.g., body temperature, causes the deformed martensite phase to transform to the austenite phase and during this phase transformation the metal reverts back to its original shape.
The term “shape memory” is used in the art to describe the property of an elastic material to recover a pre-programmed shape after deformation of a shape memory alloy in its martensitic phase and exposing the alloy to a temperature excursion through its austenite transformation temperature, at which temperature the alloy begins to revert to the austenite phase and recover its preprogrammed shape. The term “pseudoelasticity” is used to describe a property of shape memory alloys where the alloy is stressed at a temperature above the transformation temperature of the alloy and stress-induced martensite is formed above the normal martensite formation temperature. Because it has been formed above its normal temperature, stress-induced martensite reverts immediately to undeformed austenite as soon as the stress is removed provided the temperature remains above the transformation temperature.
The present invention employs a wire member made of either a shape memory alloy, preferably a nickel-titanium alloy known as NITINOL, spring stainless steel or other elastic metal or plastic alloys, or composite material, such as carbon fiber. It is preferable that the wire member have either a generally circular, semi-circular, triangular or quadrilateral transverse cross-sectional profile. Where a shape memory alloy material is employed, pre-programmed shape memory is imparted to the wire member by helically winding the wire member about a cylindrical programming mandrel having an outer diametric dimension substantially the same, preferably within a tolerance of about +0 to −15%, as the ePTFE substrate and annealing the programming mandrel and the wire member at a temperature and for a time sufficient to impart the desired shape memory to the wire member. After annealing, the wire member is removed from the programming mandrel, straightened and helically wound about the abluminal wall surface of an ePTFE tubular member at a temperature below the As of the shape memory alloy used to form the wire member.
In order to facilitate bonding of the wire member to the ePTFE tubular member, it is preferable that a bonding agent capable of bonding the support wire member to the ePTFE tubular member be used at the interface between the wire member and the ePTFE tubular member. Suitable biocompatible bonding agents may be selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone. The bonding agent may constitute an interfacial layer intermediate the wire member and the ePTFE tubular member, or may be a polymeric cladding at least partially concentrically surrounding the wire member.
Where a cladding is provided, the cladding is preferably a polymeric material selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone. The cladding may be either co-extruded with the wire member, extruded as a tube into which the wire member is concentrically inserted after annealing the wire member, or provided as an elongate member which a longitudinal recess which co-axially receives the wire member. Where the bonding agent employed is a melt thermoplastic which has a melt point below the crystalline melt point of polytetrafluoroethylene, the melt thermoplastic bonding agent and the wire member are wound about the ePTFE tubular member, and constrained thereupon, such as by application of circumferential pressure, then the assembly is then exposed to the melt temperatures without longitudinally supporting the assembly.
However, where the bonding agent is polytetrafluoroethylene, bonding of the wire member to the ePTFE tubular member requires exposing the assembly to temperatures above the crystalline melt point of polytetrafluoroethylene in order to effectuate bonding of the wire member to the ePTFE. This is preferably accomplished by introducing the assembly into a sintering oven while the assembly is on a mandrel and the assembly secured to the mandrel by an external helical wrapping of TEFLON tape applied to opposing ends of the assembly to longitudinally constrain the assembly and reduce or eliminate the tendency of the assembly to longitudinally foreshorten during sintering.
It is a primary objective of the present invention to provide a self-supporting, self-expanding stent-graft device which is capable of being delivered to an anatomical position within a human body in a first constrained configuration, positioned in vivo at a desired anatomical site, and the constraint released to permit the stent-graft device to transform to a radially enlarged second configuration.
It is another primary objective of the present invention to provide a stent-graft device which consists generally of tubular member fabricated of a biocompatible polymer selected from the group of microporous expanded polytetrafluoroethylene (“ePTFE”), polyethylene, polyethylene terepthalate, polyurethane and collagen, and at least one winding of a elastically self-expanding wire coupled to either the abluminal or luminal surfaces of the ePTFE tubular member or interdisposed between concentrically positioned ePTFE tubular members.
It is a further objective of the present invention to couple the at least one winding of the elastically self-expanding wire to the ePTFE tubular member by cladding a support wire in a polymeric material which has a melt point less than or equal to that of the ePTFE tubular member and below the A, temperature of the shape memory alloy metal wire.
It is a further objective of the present invention to provide an adhesive interlayer for bonding the shape memory alloy metal wire to the tubular member, the adhesive interlayer being selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone, fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone.
It is another objective of the present invention to provide a method for making a—expanding stent-graft device comprised generally of an ePTFE tubular member and at least one winding of a shape memory alloy metal wire coupled to the abluminal surface of the ePTFE tubular member.
These and other objects, features and advantages of the present invention will be better understood by those of ordinary skill in the art from the following more detailed description of the present invention taken with reference to the accompanying drawings and its preferred embodiments.
The shape memory alloy supported intraluminal graft 10 of the present invention consists generally of a tubular substrate 12 having a central lumen 13 passing through an entire longitudinal extent of the tubular substrate. The tubular substrate 12 has a luminal wall surface 15 adjacent the central lumen 13 and an abluminal wall surface 17 opposing the central lumen 13. A support member 14 is provided and is preferably at least partially covered by a polymeric cladding 11. The polymeric clad support member 14 is circumferentially disposed about and joined to the abluminal wall surface 17 of the tubular substrate 12, such as by helically winding the polymeric clad support member 14 about the abluminal surface 17 of the tubular substrate 12. Optionally, a second tubular substrate 19, having an inner diameter sufficiently dimensioned to be concentrically engaged about the abluminal wall surface 17 of the tubular substrate 12 and the polymeric clad support member 14, may be provided.
In accordance with a first preferred embodiment of the present invention, and with particular reference to
The resulting tubular ePTFE material has a microporous microstructure which is composed of spaced-apart nodes interconnected by fibrils, with the fibrils being oriented parallel to the longitudinal axis of the ePTFE tube and parallel to the axis of longitudinal expansion. U.S. Pat. Nos. '390 and '566, both issued to Gore, teach processes for making ePTFE tubular substrates and are hereby incorporated by reference as teaching processes to make ePTFE tubular and planar materials. A tubular substrate may also be made by weaving yarn, made of either polyester or ePTFE, into a tubular structure as is well known in the art. Additionally, the tubular substrate 12 may have a cylindrical profile having a substantially uniform internal diameter along its longitudinal axis, or may have a tapered sidewall in which the tubular substrate 12 assumes a generally frustroconical shape in which the internal diameter of the tubular substrate 12 increases or deceases along the longitudinal axis of the tubular substrate 12. Alternatively, the tubular substrate 12 may have at least one region of stepped diameter in which the internal diameter of the tubular substrate changes at a discrete longitudinal section of the tubular substrate 12.
In accordance with a first preferred embodiment of the present invention, the tubular substrate 12 is an extruded, longitudinally expanded and sintered ePTFE tubular member which has been radially expanded from an initial luminal inner diameter of between about 1.5 mm to about 6 mm to a final luminal inner diameter of between about 3 mm to about 18 mm. Thus, tubular substrate 12 is initially fabricated at a first relatively smaller diametric dimension, dried of the hydrocarbon lubricant, and sintered, then radially expanded by application of an radially outwardly directed force applied to the luminal wall surface 15 of the tubular substrate 12, which radially deforms the wall of the tubular substrate 12 from an initial luminal inner diameter, denoted D1, to a second, enlarged luminal inner diameter, denoted D2. Alternatively, tubular substrate 12 may be provided as an extruded, longitudinally expanded and sintered ePTFE tubular member having an inner diameter equivalent to the final inner diameter of the supported intraluminal graft, e.g., extruded to a luminal diameter of between about 3 mm to about 18 mm, and a wall thickness sufficient to acceptably minimize the delivery profile of the supported intraluminal graft. Suitable wall thicknesses for the non-radially expanded ePTFE tubular member are considered less than or equal to about 0.3 mm for delivery to peripheral anatomic passageways.
The tubular substrate 12 is preferably radially expanded by loading the tubular substrate 12, in its fully or partially sintered state, onto an inflation balloon such that the tubular substrate 12 is concentrically engaged upon the inflation balloon, introducing the inflation balloon and tubular substrate 12 into a tubular housing defining a generally cylindrical cavity having an inner diameter corresponding to the maximum desired outer diameter of the final shape memory alloy supported graft, and applying a fluid pressure to the inflation balloon to inflate the inflation balloon and radially deform the tubular substrate 12 into intimate contact with the generally cylindrical cavity. Pressure is maintained within the inflation balloon for a period of time sufficient to minimize the inherent recoil property of the ePTFE material in the tubular substrate 12, then the pressure is relieved and the inflation balloon permitted to deflate. The radially deformed tubular substrate, now having an inner luminal diameter D2, is removed from the generally cylindrical cavity for subsequent processing.
During radial expansion of the tubular substrate 12 from D1 to D2, the node and fibril microstructure of the ePTFE tubular substrate is deformed. The nodes, which have an orientation perpendicular to the longitudinal axis of the tubular substrate 12 and parallel to the radial axis of the tubular substrate 12, deform along the longitudinal axis of each node to form elongated columnar structures, while the length of the fibrils interconnecting adjacent pairs of nodes in the longitudinal axis of the tubular substrate 12, remains substantially constant. The fibril length is also referred to herein as the “internodal distance.”
A support member 14, which is preferably made of an elastic wire material selected from the group of thermoelastic or shape memory alloys, spring stainless steel, elastic metal or plastic alloys, or composite materials, such as woven carbon fibers. Where a shape memory alloy is employed, it is important that the shape memory alloy have a transition temperature below human body temperature, i.e., 37 degrees Celsius, to enable the shape memory alloy to undergo transformation to the austenite phase when the shape memory alloy wire member is exposed to human body temperature in vivo. In accordance with the best mode currently known for the present invention, the preferred shape memory alloy is a near equiatomic alloy of nickel and titanium.
To facilitate attachment of the elastic or thermoelastic wire member 14 to the tubular substrate 12, it is contemplated that a polymeric cladding 11 be provided to at least partially cover the support wire member 14 and facilitate adhesion between the support wire member 14 and the abluminal wall surface 17 of the tubular substrate 12. In accordance with the best mode for practicing the present invention, it is preferable that the polymeric cladding 11 be selected from the group of biocompatible polymeric materials consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone, fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone.
As will hereinafter be described more fully, the polymeric cladding 11 may be coupled to the support wire member 14 by any of a variety of known methodologies. For example, the polymeric cladding 11 may be co-extruded with the support wire member 14, the polymeric cladding 11 may be extruded with an opening passing through the polymeric cladding 11 along its longitudinal axis and dimensioned to receive the support wire member 14 there through, the polymeric cladding 11 may have a longitudinally extending recess dimensioned to receive and retain the support wire member 14 therein, or the polymeric cladding 11 may be applied onto the support wire member 11 in dispersion form, such as by dipcoating or spraying, and the solvent or aqueous vehicle dried thereby forming a covering on the support wire member 11.
The support wire member 14 in its polymeric cladding 11 is circumferentially joined to the abluminal wall surface 17 of the tubular substrate 12, such as by helically winding at least one length of polymeric clad support wire member 14 in a regular or irregular helical pattern, or by applying the polymeric clad support wire member 14 as a series of spaced-apart circumferential rings, along at least a portion of the longitudinal axis of the abluminal wall surface 17 of the tubular substrate 12. It is preferable that the tubular substrate 12 be mounted onto a supporting mandrel [not shown] having an outer diameter closely toleranced to the inner diameter of the tubular substrate 12 to permit the tubular substrate 12 to be placed thereupon and secured thereto without deforming the tubular substrate 12.
A second tubular member 19 may, optionally, be concentrically engaged about the tubular member 12 and the polymeric clad support wire member 14. As more clearly depicted in
After wrapping the polymeric clad support wire member 14 about the abluminal surface of the tubular member 12, and circumferentially engaging the second tubular member 19 thereabout, it is preferable to apply a circumferential pressure to the assembly, while the assembly is on the supporting mandrel [not shown]. Circumferential pressure may be applied to the assembly by, for example, helically wrapping tetrafluoroethylene film tape about the abluminal surface of the second tubular member 19 along its longitudinal axis, or by securing opposing ends of the assembly on the supporting mandrel, and rolling the assembly to calendar the assembly. After the circumferential pressure is applied to the assembly, the assembly is then introduced into either a convention or radiant heating oven, set at a temperature above the melt point of the material used to fabricate the tubular member 12, the second tubular member 19 and/or the polymeric cladding 11, for a period of time sufficient to bond the tubular member 12, the second tubular member 19 and the polymeric cladding 11 into a substantially monolithic, unitary structure. Where polytetrafluoroethylene is used, it has been found that it is preferable to heat the assembly in a radiant heating oven.
The helical winding of the polymeric clad support wire member 14 contacts the abluminal wall surface 17 of the tubular member 12 at an interfacial region 28. According to one preferred embodiment of the present invention there is provided an adhesive material 23 selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone, fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone. The adhesive material is preferably applied to the interfacial region 28 of the polymeric clad support wire member 14, but may also be applied in a pattern directly to a surface of the tubular substrate and the SMA wire member 14 brought into contact with the adhesive material. In this manner, as the polymeric clad support wire member 28 is helically applied to the abluminal wall surface 17 of the tubular member 12, the adhesive material 23 forms an interlayer intermediate the polymeric clad support wire member 28 and the abluminal wall surface 17 of the tubular member 12.
Where the selected adhesive material 23 has a melt point less than the crystalline melt point of polytetrafluoroethylene, i.e., about 327 degrees Centigrade, the resulting assembly of step 25 may be introduced into a heating oven set at the melt temperature of the selected adhesive material 23, for a period of time sufficient to melt the adhesive material 23 and impart an adhesive bond between the polymeric clad support wire member 14 and the tubular member 12. On the other hand, where the selected adhesive material 23 is polytetrafluoroethylene, an external covering of a second tubular member 26 may be concentrically engaged about the assembly resulting from step 25, a circumferential pressure exerted to the second tubular member 26, thereby bringing the second tubular member 26, the polymer clad support wire member 11 and the tubular member 12 into intimate contact with one another, and the entire assembly introduced into a sintering oven set at a temperature above the crystalline melt point of polytetrafluoroethylene and for a period of time sufficient to meld the second tubular member 26 and the tubular member 12 to one another to form a resultant substantially monolithic structure which is substantially devoid of interfacial demarcations between the second tubular member 26 and the tubular member 12, with the polymer clad support wire member 14 residing intermediate there between.
Turning now to
As depicted in
It will be understood by those skilled in the art, that each of the foregoing embodiments of the polymer clad support wire member may be made by pulltrusion methods in which the shape memory alloy wire member, having a pre-programmed austenite phase, is fed into an extruder during extrusion of the polymer cladding, or by extruding the polymer cladding with a central lumen, dimensioned appropriately to permit engagement of the shape memory alloy wire, then threading the support wire member into the central lumen of the polymer cladding.
Finally, an alternative embodiment of a shape memory alloy supported intraluminal graft 80 is depicted in
The inventive method 100 for making the inventive wire supported intraluminal graft, described above, is illustrated with reference to
Where a thermoelastic shape memory alloy (SMA) wire member is utilized, the SMA wire member is wound about the shaping mandrel, the shape of the wound SMA wire member is programmed at step 108 by annealing the SMA wire member at a temperature and for a time sufficient to impart shape memory properties to the SMA wire member. At step 110, the preprogrammed SMA alloy wire member is then exposed to temperature conditions below the Mf temperature of the SMA alloy. While it is maintained below the Mf temperature of the SMA alloy, the wire member is removed from the shaping mandrel and straightened to a linear shape at step 112. If the SMA alloy wire member is to be covered with a cladding, a polymeric tubular cladding is provided at step 118 and the SMA alloy wire member is threaded into the lumen of the tubular cladding at step 120.
It is preferable that steps 118 and 120 be performed while the SMA alloy wire member is maintained at a temperature below the Mf temperature of the SMA alloy to prevent shape recovery of the SMA alloy wire member. Alternatively, if no polymeric cladding is to be employed, but the SMA alloy wire member from step 112 is to be adhered, an adhesive material may be applied to the SMA alloy wire member at step 122. Step 122 may be conducted while the SMA alloy wire member is at a temperature below the Mf temperature, however, due to the fact that most adhesives may not adhere to the SMA alloy wire member at such temperatures, the adhesive is preferably applied to the SMA alloy wire member while it is in the austenite state. Where an elastic wire member, such as a support structure made from stainless steel spring wire, is employed, the shape programming described in the preceding paragraph may, of course, be omitted.
After application of the polymeric cladding at steps 118 and 120, or after the adhesive is applied at step 122, or where step 122 is conducted at a temperature below the Mf temperature of the SMA alloy, the SMA wire is then exposed to a temperature excursion to above the Af temperature of the SMA alloy at step 114 so that the SMA alloy wire member recovers its programmed shape at step 116. Where an elastic wire member is employed, it is not sensitive to temperature excursions and the temperature excursion step may be omitted.
A tubular substrate, made of, for example, extruded ePTFE, preferably extruded ePTFE which has been radially deformed from its nominal extruded diameter to an enlarged diameter, or woven polyester, is provided at step 123. The wire member in its enlarged shape, which in the case of an SMA wire member is its programmed shape, or in the case of an elastic wire member, in its unstressed state, is concentrically engaged about the tubular substrate at step 124, and joined to the tubular substrate at step 126 by thermally bonding the adhesive or the polymeric cladding to the abluminal or luminal surface of the tubular substrate. It is preferable that step 126 be conducted while the tubular substrate is supported by a support mandrel and that the SMA alloy wire member is retained in intimate contact with a surface of the tubular substrate with at least a portion of the wire member. The wire member, either in its clad or unclad state, may be retained in intimate contact against either by tension wrapping the wire member or by an external covering wrap of a release material, such as polytetrafluoroethylene tape, to cover at least a portion of the wire member.
After the wire member is joined to the tubular substrate, the assembly may optionally be sterilized at step 128, such as by exposure to ethylene oxide for a time and under appropriate conditions to sterilize the assembly. Where an SMA alloy wire member is employed, the assembly is then exposed to a temperature below the AS temperature of the SMA alloy wire member at step 130 and the assembly is mechanically deformed to a smaller diametric profile at step 132. Where an elastic wire member is employed, the assembly is mechanically deformed to a smaller diametric profile at step 132 largely independent of temperature conditions. Step 132 may be performed by any suitable means to reduce the diametric profile of the assembly, such as by drawing it through a reducing die, manually manipulating the assembly to a reduced diametric profile, or folding the device.
The reduced profile assembly is then loaded onto a delivery catheter and covered with a restraining sheath at step 134. Once loaded onto a delivery catheter and covered with a restraining sheath to prevent shape recovery. In the case where the wire member is an SMA alloy, loading the assembly onto a delivery catheter and covering with a restraining sheath requires that step 134 be performed at a temperature below the AS temperature of the SMA alloy wire in order to prevent thermoelastic recovery of the SMA alloy wire member. Where, however, the wire member is fabricated of an elastic material, the loading step 134 is not largely temperature sensitive and may be performed at room temperature. While the wire member will exert shape recovery forces at room temperature, e.g., above the AS temperature of the SMA alloy wire employed, the restraining sheath of the delivery catheter will prevent the SMA alloy wire member from recovering its programmed shape and carrying the tubular substrate to the programmed shape of the SMA alloy wire member. Optionally, the sterilization step 128 may also be performed after the assembly is loaded onto the delivery catheter at step 134.
While the present invention has been described with reference to its preferred embodiments and the best mode known to the inventor for making the inventive shape memory alloy supported intraluminal graft, it will be appreciated that variations in material selection for the polymer cladding, for the shape memory alloy, or process variations, such as the manner of winding the polymer clad support wire member about either a winding mandrel or a tubular member, or times and conditions of the manufacturing steps, including material selection, may be made without departing from the scope of the present invention which is intended to be limited only by the appended claims.
This application is a continuation of U.S. patent application Ser. No. 13/434,472, now U.S. Pat. No. 8,337,650, filed Mar. 29, 2012, which is a continuation of U.S. patent application Ser. No. 12/546,483, filed Aug. 24, 2009, now U.S. Pat. No. 7,578,899, which is a continuation of U.S. patent application Ser. No. 11/429,849, filed May 8, 2006, now U.S. Pat. No. 7,578,899, which is a continuation of U.S. patent application Ser. No. 10/431,685, filed May 8, 2003, now U.S. Pat. No. 7,060,150, which is a divisional of U.S. patent application Ser. No. 09/855,918, filed May 15, 2001, now abandoned, which is a divisional of U.S. patent application Ser. No. 08/999,583, filed Dec. 22, 1997, now U.S. Pat. No. 6,264,684, which is a continuation-in-part of three applications: 1) International Application No. PCT/US95/16497, filed Dec. 8, 1995, which was nationalized as U.S. patent application Ser. No. 09/077,533, filed May 28, 1998, now U.S. Pat. No. 6,053,943; 2) U.S. patent application Ser. No. 08/833,797, filed Apr. 9, 1997, now U.S. Pat. No. 6,451,047, which is a continuation-in-part of U.S. patent application Ser. No. 08/508,033, filed Jul. 27, 1995, now U.S. Pat. No. 5,749,880, which is a continuation-in-part of U.S. patent application Ser. No. 08/401,871, filed Mar. 10, 1995, now U.S. Pat. No. 6,124,523; and 3) U.S. patent application Ser. No. 08/794,871, filed Feb. 5, 1997, now U.S. Pat. No. 6,039,755. This application expressly incorporates by reference the entirety of each of the above-mentioned applications as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
612897 | Ellis | Oct 1898 | A |
1505591 | Goldfarb | Feb 1924 | A |
2642625 | Peck | Jun 1953 | A |
3027601 | Barry | Apr 1962 | A |
3060517 | Fields | Oct 1962 | A |
3105492 | Jeckel | Oct 1963 | A |
3196194 | Ely, Jr. et al. | Jul 1965 | A |
3207601 | Barry | Sep 1965 | A |
3281511 | Goldsmith | Oct 1966 | A |
3304557 | Polansky | Feb 1967 | A |
3657744 | Ersek | Apr 1972 | A |
3767500 | Tally et al. | Oct 1973 | A |
3887761 | Gore | Jun 1975 | A |
3992725 | Homsy | Nov 1976 | A |
4061517 | Dutton, III et al. | Dec 1977 | A |
4159370 | Koizumi et al. | Jun 1979 | A |
4324574 | Fagan | Apr 1982 | A |
RE31341 | Koizumi et al. | Aug 1983 | E |
4416028 | Eriksson et al. | Nov 1983 | A |
RE31618 | Mano et al. | Jul 1984 | E |
4482516 | Bowman et al. | Nov 1984 | A |
4503569 | Dotter | Mar 1985 | A |
4512338 | Balko et al. | Apr 1985 | A |
4580568 | Gianturco | Apr 1986 | A |
4588461 | Braun | May 1986 | A |
4596837 | Yamamoto et al. | Jun 1986 | A |
4604762 | Robinson | Aug 1986 | A |
4629458 | Pinchuk | Dec 1986 | A |
4647416 | Seiler, Jr. et al. | Mar 1987 | A |
4655769 | Zachariades | Apr 1987 | A |
4665906 | Jervis | May 1987 | A |
4714748 | Hoashi et al. | Dec 1987 | A |
4731073 | Robinson | Mar 1988 | A |
4733665 | Palmaz | Mar 1988 | A |
4739762 | Palmaz | Apr 1988 | A |
4747849 | Galtier | May 1988 | A |
4760102 | Moriyama et al. | Jul 1988 | A |
4767418 | Deininger et al. | Aug 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4816339 | Tu et al. | Mar 1989 | A |
4820298 | Leveen et al. | Apr 1989 | A |
4830062 | Yamamoto et al. | May 1989 | A |
4850999 | Planck | Jul 1989 | A |
4857069 | Kira | Aug 1989 | A |
4886062 | Wiktor | Dec 1989 | A |
4907336 | Gianturco | Mar 1990 | A |
4922905 | Strecker et al. | May 1990 | A |
4935068 | Duerig | Jun 1990 | A |
4954126 | Wallsten et al. | Sep 1990 | A |
4955899 | Della Corna et al. | Sep 1990 | A |
4957669 | Primm | Sep 1990 | A |
4969458 | Wiktor | Nov 1990 | A |
4969896 | Shors | Nov 1990 | A |
5019090 | Pinchuk | May 1991 | A |
5061275 | Wallsten et al. | Oct 1991 | A |
5061276 | Tu et al. | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5067957 | Jervis | Nov 1991 | A |
5071609 | Tu et al. | Dec 1991 | A |
5078726 | Kreamer | Jan 1992 | A |
5078736 | Behl | Jan 1992 | A |
5084065 | Weldon et al. | Jan 1992 | A |
5102417 | Palmaz | Apr 1992 | A |
5116360 | Pinchuk et al. | May 1992 | A |
5116365 | Hillstead | May 1992 | A |
5122154 | Rhodes | Jun 1992 | A |
5123917 | Lee | Jun 1992 | A |
5124523 | Oehlmann et al. | Jun 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
5135503 | Abrams | Aug 1992 | A |
5139480 | Hickle et al. | Aug 1992 | A |
5143085 | Wilson | Sep 1992 | A |
5152782 | Kowligi et al. | Oct 1992 | A |
5156620 | Pigott | Oct 1992 | A |
5158548 | Lau et al. | Oct 1992 | A |
5163951 | Pinchuk et al. | Nov 1992 | A |
5167614 | Tessmann et al. | Dec 1992 | A |
5171805 | Tatemoto et al. | Dec 1992 | A |
5192307 | Wall | Mar 1993 | A |
5195984 | Schatz | Mar 1993 | A |
5211658 | Clouse | May 1993 | A |
5219355 | Parodi et al. | Jun 1993 | A |
5219361 | von Recum et al. | Jun 1993 | A |
5231989 | Middleman et al. | Aug 1993 | A |
5234456 | Silvestrini | Aug 1993 | A |
5234739 | Tanaru et al. | Aug 1993 | A |
5236446 | Dumon | Aug 1993 | A |
5236447 | Kubo et al. | Aug 1993 | A |
5242399 | Lau et al. | Sep 1993 | A |
5258027 | Berghaus et al. | Nov 1993 | A |
5282823 | Schwartz et al. | Feb 1994 | A |
5282824 | Gianturco | Feb 1994 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5282848 | Schmitt | Feb 1994 | A |
5282849 | Kolff et al. | Feb 1994 | A |
5282860 | Matsuno et al. | Feb 1994 | A |
5316023 | Palmaz et al. | May 1994 | A |
5330500 | Song et al. | Jul 1994 | A |
5334201 | Cowan | Aug 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5349964 | Imran et al. | Sep 1994 | A |
5354309 | Schnepp-Pesch et al. | Oct 1994 | A |
5354329 | Whalen | Oct 1994 | A |
5360443 | Barone et al. | Nov 1994 | A |
5366504 | Andersen et al. | Nov 1994 | A |
5370681 | Herweck et al. | Dec 1994 | A |
5370691 | Samson | Dec 1994 | A |
5376110 | Tu et al. | Dec 1994 | A |
5382261 | Palmaz | Jan 1995 | A |
5383106 | Yoshida et al. | Jan 1995 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5383926 | Lock et al. | Jan 1995 | A |
5383928 | Scott et al. | Jan 1995 | A |
5384019 | Keating et al. | Jan 1995 | A |
5385580 | Schmitt | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5387236 | Noishiki et al. | Feb 1995 | A |
5389106 | Tower | Feb 1995 | A |
5395390 | Simon et al. | Mar 1995 | A |
5405377 | Cragg | Apr 1995 | A |
5405378 | Strecker et al. | Apr 1995 | A |
5411476 | Abrams et al. | May 1995 | A |
5421955 | Lau et al. | Jun 1995 | A |
5429869 | McGregor et al. | Jul 1995 | A |
5433996 | Kranzler et al. | Jul 1995 | A |
5437083 | Williams et al. | Aug 1995 | A |
5443496 | Schwartz et al. | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5452726 | Burmeister et al. | Sep 1995 | A |
5458615 | Klemm et al. | Oct 1995 | A |
5464438 | Menaker | Nov 1995 | A |
5464440 | Johansson et al. | Nov 1995 | A |
5464449 | Ryan et al. | Nov 1995 | A |
5474563 | Myler et al. | Dec 1995 | A |
5489295 | Piplani et al. | Feb 1996 | A |
5496364 | Schmitt | Mar 1996 | A |
5500013 | Buscemi et al. | Mar 1996 | A |
5507767 | Maeda et al. | Apr 1996 | A |
5507768 | Lau et al. | Apr 1996 | A |
5507769 | Marin et al. | Apr 1996 | A |
5507771 | Gianturco | Apr 1996 | A |
5514115 | Frantzen et al. | May 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5522881 | Lentz | Jun 1996 | A |
5522883 | Slater et al. | Jun 1996 | A |
5523092 | Hanson et al. | Jun 1996 | A |
5527353 | Schmitt | Jun 1996 | A |
5527355 | Ahn | Jun 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5540713 | Schnepp-Pesch et al. | Jul 1996 | A |
5546646 | Williams et al. | Aug 1996 | A |
5549635 | Solar | Aug 1996 | A |
5549663 | Cottone, Jr. | Aug 1996 | A |
5554181 | Das | Sep 1996 | A |
5556389 | Liprie | Sep 1996 | A |
5556413 | Lam | Sep 1996 | A |
5556414 | Turi | Sep 1996 | A |
5556426 | Popadiuk et al. | Sep 1996 | A |
5562725 | Schmitt et al. | Oct 1996 | A |
5569295 | Lam | Oct 1996 | A |
5571170 | Palmaz et al. | Nov 1996 | A |
5571171 | Barone et al. | Nov 1996 | A |
5571173 | Parodi et al. | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5591197 | Orth et al. | Jan 1997 | A |
5591222 | Susawa et al. | Jan 1997 | A |
5591223 | Lock et al. | Jan 1997 | A |
5591224 | Schwartz et al. | Jan 1997 | A |
5591228 | Edoga | Jan 1997 | A |
5591229 | Parodi et al. | Jan 1997 | A |
5591288 | Becker et al. | Jan 1997 | A |
5593417 | Rhodes | Jan 1997 | A |
5597378 | Jervis | Jan 1997 | A |
5603721 | Lau et al. | Feb 1997 | A |
5607445 | Summers | Mar 1997 | A |
5607478 | Lentz et al. | Mar 1997 | A |
5609624 | Kalis | Mar 1997 | A |
5620763 | House et al. | Apr 1997 | A |
5628786 | Banas et al. | May 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5630806 | Inagaki et al. | May 1997 | A |
5630829 | Lauterjung | May 1997 | A |
5630840 | Mayer | May 1997 | A |
5632840 | Campbell | May 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5645559 | Hachtman et al. | Jul 1997 | A |
5649950 | Bourne et al. | Jul 1997 | A |
5649977 | Campbell | Jul 1997 | A |
5653727 | Wiktor | Aug 1997 | A |
5653747 | Dereume et al. | Aug 1997 | A |
5665117 | Rhodes | Sep 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5674241 | Bley et al. | Oct 1997 | A |
5674277 | Freitag | Oct 1997 | A |
5676671 | Inoue et al. | Oct 1997 | A |
5681345 | Euteneuer | Oct 1997 | A |
5683448 | Cragg | Nov 1997 | A |
5683453 | Palmaz | Nov 1997 | A |
5693085 | Buirge et al. | Dec 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5700285 | Myers et al. | Dec 1997 | A |
5700286 | Tartaglia et al. | Dec 1997 | A |
5713949 | Jayaraman et al. | Feb 1998 | A |
5716393 | Lindenberg et al. | Feb 1998 | A |
5718159 | Thompson | Feb 1998 | A |
5718973 | Lewis et al. | Feb 1998 | A |
5719873 | Yamashita et al. | Feb 1998 | A |
5723003 | Winston et al. | Mar 1998 | A |
5723004 | Dereume et al. | Mar 1998 | A |
5728131 | Frantzen et al. | Mar 1998 | A |
5728158 | Lau et al. | Mar 1998 | A |
5735892 | Myers et al. | Apr 1998 | A |
5735893 | Lau et al. | Apr 1998 | A |
5738674 | Williams et al. | Apr 1998 | A |
5749880 | Banas et al. | May 1998 | A |
5755770 | Ravenscroft | May 1998 | A |
5755774 | Pinchuk | May 1998 | A |
5755781 | Jayaraman et al. | May 1998 | A |
5766238 | Lau et al. | Jun 1998 | A |
5769817 | Burgmeier | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5776161 | Globerman et al. | Jul 1998 | A |
5782904 | White et al. | Jul 1998 | A |
5788626 | Thompson | Aug 1998 | A |
5800512 | Lentz et al. | Sep 1998 | A |
5810870 | Myers et al. | Sep 1998 | A |
5824037 | Fogarty et al. | Oct 1998 | A |
5824043 | Cottone, Jr. | Oct 1998 | A |
5824046 | Smith et al. | Oct 1998 | A |
5824053 | Khosravi et al. | Oct 1998 | A |
5824054 | Khosravi et al. | Oct 1998 | A |
5843161 | Solovay | Dec 1998 | A |
5843166 | Lentz et al. | Dec 1998 | A |
5849037 | Frid et al. | Dec 1998 | A |
5851232 | Lois | Dec 1998 | A |
5863366 | Snow | Jan 1999 | A |
5871536 | Lazarus | Feb 1999 | A |
5871537 | Holman et al. | Feb 1999 | A |
5873906 | Lau et al. | Feb 1999 | A |
5876448 | Thompson et al. | Mar 1999 | A |
5919225 | Lau et al. | Jul 1999 | A |
5925061 | Ogi et al. | Jul 1999 | A |
5928279 | Shannon et al. | Jul 1999 | A |
5961545 | Lentz et al. | Oct 1999 | A |
5968070 | Bley et al. | Oct 1999 | A |
5968091 | Pinchuk et al. | Oct 1999 | A |
6001125 | Golds et al. | Dec 1999 | A |
6004348 | Banas et al. | Dec 1999 | A |
6010529 | Herweck et al. | Jan 2000 | A |
6010530 | Goicoechea | Jan 2000 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6036724 | Lentz et al. | Mar 2000 | A |
6039755 | Edwin et al. | Mar 2000 | A |
6042605 | Martin et al. | Mar 2000 | A |
6048484 | House et al. | Apr 2000 | A |
6053943 | Edwin et al. | Apr 2000 | A |
6063111 | Hieshima et al. | May 2000 | A |
6090127 | Globerman | Jul 2000 | A |
6120535 | McDonald et al. | Sep 2000 | A |
6124523 | Banas et al. | Sep 2000 | A |
6139573 | Sogard et al. | Oct 2000 | A |
6149681 | Houser et al. | Nov 2000 | A |
6156062 | McGuinness | Dec 2000 | A |
6165210 | Lau et al. | Dec 2000 | A |
6214039 | Banas et al. | Apr 2001 | B1 |
6264684 | Banas et al. | Jul 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6309343 | Lentz et al. | Oct 2001 | B1 |
6309413 | Dereume et al. | Oct 2001 | B1 |
6312454 | Stockel et al. | Nov 2001 | B1 |
6364903 | Tseng et al. | Apr 2002 | B2 |
6364904 | Smith | Apr 2002 | B1 |
6375787 | Lukic et al. | Apr 2002 | B1 |
6379379 | Wang | Apr 2002 | B1 |
6383214 | Banas et al. | May 2002 | B1 |
6398803 | Layne et al. | Jun 2002 | B1 |
6451047 | McCrea et al. | Sep 2002 | B2 |
6451052 | Burmeister et al. | Sep 2002 | B1 |
6488701 | Nolting et al. | Dec 2002 | B1 |
6497671 | Ferrera et al. | Dec 2002 | B2 |
6524334 | Thompson | Feb 2003 | B1 |
6547814 | Edwin et al. | Apr 2003 | B2 |
6579314 | Lombardi et al. | Jun 2003 | B1 |
6585760 | Fogarty | Jul 2003 | B1 |
6673103 | Golds et al. | Jan 2004 | B1 |
6673105 | Chen | Jan 2004 | B1 |
6733524 | Tseng et al. | May 2004 | B2 |
6740115 | Lombardi et al. | May 2004 | B2 |
6758858 | McCrea et al. | Jul 2004 | B2 |
6770086 | Girton | Aug 2004 | B1 |
6770087 | Layne et al. | Aug 2004 | B2 |
6786920 | Shannon et al. | Sep 2004 | B2 |
6790225 | Shannon et al. | Sep 2004 | B1 |
6790226 | Edwin et al. | Sep 2004 | B2 |
6797217 | McCrea et al. | Sep 2004 | B2 |
6808533 | Goodwin et al. | Oct 2004 | B1 |
7060150 | Banas et al. | Jun 2006 | B2 |
7083640 | Lombardi et al. | Aug 2006 | B2 |
7288111 | Holloway et al. | Oct 2007 | B1 |
7306756 | Edwin et al. | Dec 2007 | B2 |
7462190 | Lombardi | Dec 2008 | B2 |
7578899 | Edwin et al. | Aug 2009 | B2 |
7914639 | Layne et al. | Mar 2011 | B2 |
7939000 | Edwin et al. | May 2011 | B2 |
8137605 | McCrea et al. | Mar 2012 | B2 |
8157940 | Edwin et al. | Apr 2012 | B2 |
8196279 | Schlun | Jun 2012 | B2 |
8337650 | Edwin et al. | Dec 2012 | B2 |
20010010012 | Edwin et al. | Jul 2001 | A1 |
20010021870 | Edwin et al. | Sep 2001 | A1 |
20010032009 | Layne et al. | Oct 2001 | A1 |
20010039446 | Edwin et al. | Nov 2001 | A1 |
20020040237 | Lentz et al. | Apr 2002 | A1 |
20030004559 | Lentz et al. | Jan 2003 | A1 |
20030006528 | Edwin et al. | Jan 2003 | A1 |
20030144725 | Lombardi | Jul 2003 | A1 |
20030191519 | Lombardi et al. | Oct 2003 | A1 |
20030201058 | Banas et al. | Oct 2003 | A1 |
20040024442 | Sowinski et al. | Feb 2004 | A1 |
20040162603 | Golds et al. | Aug 2004 | A1 |
20040162604 | Sowinski et al. | Aug 2004 | A1 |
20040181278 | Tseng et al. | Sep 2004 | A1 |
20040204757 | Lombardi et al. | Oct 2004 | A1 |
20040232588 | Edwin et al. | Nov 2004 | A1 |
20040236400 | Edwin et al. | Nov 2004 | A1 |
20040236402 | Layne et al. | Nov 2004 | A1 |
20050055081 | Goodwin et al. | Mar 2005 | A1 |
20050060020 | Jenson | Mar 2005 | A1 |
20050096737 | Shannon et al. | May 2005 | A1 |
20050113909 | Shannon et al. | May 2005 | A1 |
20050131515 | Cully et al. | Jun 2005 | A1 |
20050131527 | Pathak | Jun 2005 | A1 |
20060201609 | Edwin et al. | Sep 2006 | A1 |
20060229714 | Lombardi et al. | Oct 2006 | A1 |
20070207186 | Scanlon et al. | Sep 2007 | A1 |
20090125092 | McCrea et al. | May 2009 | A1 |
20090294035 | Layne et al. | Dec 2009 | A1 |
20090311132 | Banas et al. | Dec 2009 | A1 |
20110126966 | Layne et al. | Jun 2011 | A1 |
20110196473 | McCrea et al. | Aug 2011 | A1 |
20120145318 | McCrea et al. | Jun 2012 | A1 |
20120193018 | Banas et al. | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
2215027 | Sep 1996 | CA |
03918736 | Dec 1990 | DE |
19524653 | Jun 1996 | DE |
0146794 | Jul 1985 | EP |
0146794 | Jul 1985 | EP |
0221570 | May 1987 | EP |
0221570 | May 1987 | EP |
0335341 | Oct 1989 | EP |
0335341 | Oct 1989 | EP |
0461791 | Dec 1991 | EP |
0461791 | Dec 1991 | EP |
0551179 | Jul 1993 | EP |
0551179 | Jul 1993 | EP |
0603959 | Jun 1994 | EP |
0646365 | Apr 1995 | EP |
0646365 | Apr 1995 | EP |
0648869 | Apr 1995 | EP |
0648869 | Apr 1995 | EP |
0656196 | Jun 1995 | EP |
0656196 | Jun 1995 | EP |
0662307 | Jul 1995 | EP |
0662307 | Jul 1995 | EP |
0667132 | Aug 1995 | EP |
0667132 | Aug 1995 | EP |
0689805 | Jan 1996 | EP |
0689806 | Jan 1996 | EP |
0716835 | Jun 1996 | EP |
0730848 | Sep 1996 | EP |
0734698 | Oct 1996 | EP |
0747022 | Dec 1996 | EP |
0749729 | Dec 1996 | EP |
0749729 | Dec 1996 | EP |
0792627 | Sep 1997 | EP |
0814729 | Jan 1998 | EP |
0893108 | Jan 1999 | EP |
2671482 | Jul 1992 | FR |
1505591 | Mar 1978 | GB |
2281865 | Mar 1995 | GB |
2002510985 | Apr 2002 | JP |
9412136 | Jun 1994 | WO |
9413224 | Jun 1994 | WO |
9424961 | Nov 1994 | WO |
9505132 | Feb 1995 | WO |
9505277 | Feb 1995 | WO |
9505555 | Feb 1995 | WO |
PCTUS9511817 | Sep 1995 | WO |
9600103 | Jan 1996 | WO |
9612517 | May 1996 | WO |
9622745 | Aug 1996 | WO |
9625897 | Aug 1996 | WO |
9628115 | Sep 1996 | WO |
9633066 | Oct 1996 | WO |
9637165 | Nov 1996 | WO |
9640000 | Dec 1996 | WO |
9707751 | Mar 1997 | WO |
9721401 | Jun 1997 | WO |
9721403 | Jun 1997 | WO |
9800090 | Jan 1998 | WO |
9826731 | Jun 1998 | WO |
9831305 | Jul 1998 | WO |
9831305 | Jul 1998 | WO |
9831306 | Jul 1998 | WO |
9838947 | Sep 1998 | WO |
9838947 | Sep 1998 | WO |
0045742 | Aug 2000 | WO |
9510700 | Nov 1996 | ZA |
Entry |
---|
Association for the Advancement of Medical Instrumentation, “Cardiovascular implants—Vascular prostheses” ANSI/AMI, vol. 20. (1994). |
Briskman, et al., “A Study of the Crystallinity of Polytetrafluoroethylene by X-Ray Diffraction Analysis and Differential Scanning Calorimetry,” Vysokomol. Soedin , Kratk. Soobshcheniya. vol. 31, No. 7, pp. 539-543. 1989. |
Chuter, T., “Bifurcated endovascular graft insertion for abdominal aortic aneurysm” Vascular and Endovascular Surgical Techniques, An Atlas Third Edition, pp. 92-99 (1994). |
Cragg, A. and Dake, M., “Persutaneous Femoropopliteal Graft Placement,” Interventional Radiology 187(30: 643-648 (Jun. 1993). |
Dietrich, E. and Papazoglou, K. Endoluminal Grafting for Aneurysmal and Occlusive Disease in the Superficial Femoral Artery: Early Experience, J. Endovase Surgery, 2:225-239(1995). |
Dorros et al., “Closure of a Popliteal Arteriovenous Fistula Using an Autologous Vein-Covered Palmaz Stent,” J Endovasc Surgery, 2:177-181 (1995). |
Heuser et al.,“Endoluminal Grafting for Percutaneous Exclusion in an Aortocoronary Saphenous Vein Graft: The First Clinical Experience,” J Endovasc Surgery, 2:81-88 (1995). |
Hu, T., “Characterization of the crystallinity of polytetrafluoroethylene by X-ray and IR spectroscopy, differential scanning calorimetry, viscoelastic spectroscopy and the use of a density gradient tube,” Wear, 82:369-376 (1982). |
Khanna et al. “A New Differential Scanning Calorimetry based Approach for the Estimation of Thermal Conductivity of Polymer solids and Melts,” Polymer Engineering and Science, 28(16):1034-1041 (1988). |
Khanna, Y.P., “The melting temperature of polytetrafluoroethylene,” Journal of Materials Science Letters, 7(8):817-818 (1988). |
Lau et al., “Glass Transition of Poly(tetrafluoroethylene),” Macromolecules 17:1102-1104 (1984). |
Lau et al., “The Thermodynamic Properties of Polytetrafluoroethylene,” Journal of Polymer Science: Polymer Physics Edition, 22:379-405 (1984). |
Marin et al., “Transluminally placed endovascular stented graft repair for arterial trauma,” The Journal of Vascular Surgery on Compact Disc, 18(6): 11 unnumbered pages (1995). |
Marin, M.L. and Veith, F. J., “Endoluminal stented graft aorto-bifemoral reconstruction,” Vascular and Endovascular Surgical Techniques. 3rd Edition, R. M. Greenhalgh ed., W. B. Saunders Company Ltd.: Philadelphia, pp. 100-104 (1994). |
Marston et al., “Transbrachial Endovascular Exclusion of an Axillary Artery Pseudoaneurysm with PTFE-Covered Stents,” J. Endovasc Surgery, 2:172-176 (1995). |
May et al. “Transluminal placement of a prosthetic graft-stent device for treatment of subclavian artery aneurysm,” Journal of Vascular Surgery, 18(6):10556-1059. 1995. |
McClurken et al., “Physical Properties and Test Methods for Expanded Polytetrafluoroethylene (PTFE) Grafts,” American Society for Testing and Materials, 86-14077 pp. 82-93 (1984). |
Moore, W., “Transfemoral endovascular repair of abdominal aortic aneurysm using the endovascular graft system device,” Vascular and Endovascular Surgical Techniques. 3rd Edition, R. M. Greenhalgh ed., W. B. Saunders Company Ltd.: Philadelphia, pp. 78-91 (1994). |
Palmaz et al. “Uses of balloon expandable stents in combination with PTFE,” Vascular and Endovascular Surgical Techniques, an Atlas, Third Edition, pp. 36-42 (1994). |
Palmaz et al., “Use of Stents Covered With Polytetrafluoroethylene in Experimental Abdominal Aortic Aneurysm,” Journal of Vascular and Interventional Radiology, 6(6): 879-885 (1995). |
Palmaz et al.,“Physical Properties of Polytetrafluoroethylene Bypass Material After Balloon Dilation,” Journal of Vascular and Interventioanl Radiology, 7(5):657-663 (1996). |
Papazoglou et al., “International Congress VIII on Endovascular Interventions” J Endovasc Surg, 2:89-129 (1995). |
Parodi, J., “Transfemoral intraluminal graft implantation for abdominal aortic aneurysms,” Annals of Vascular Surgery, 5(6):491-499 (1991). |
PCT/US2000/02884 filed Feb. 2, 2000 International Preliminary Examination Report dated Aug. 27, 2002. |
PCT/US2000/02884 filed Feb. 2, 2000 International Seach Report dated Jul. 10, 2000. |
Shapiro, M. and Levin, D., “Percutaneous Femoropopliteal Graft Placement: Is This the Next Step?” Radiology 187(30: 618-619 (Jun. 1993). |
Starkweather, H. W. Jr., “The Density of Amorphous Polytetrafluoroethylene,” Journal of Polymer Science: Polymer Physics Editions, 20:2159-2161 (1982). |
U.S. Appl. No. 09/858,035, filed May 15, 2001 Advisory Action dated Oct. 7, 2003. |
U.S. Appl. No. 09/858,035, filed May 15, 2001 Final Office Action dated Jul. 25, 2003. |
U.S. Appl. No. 09/858,035, filed May 15, 2001 Non-Final Office Action dated Dec. 1, 2003. |
U.S. Appl. No. 09/858,035, filed May 15, 2001 Non-Final Office Action dated Oct. 1, 2002. |
U.S. Appl. No. 10/242,160, filed Sep. 12, 2002 Non-Final Office Action dated Oct. 27, 2003. |
U.S. Appl. No. 10/431,685, filed May 8, 2003 Non-Final Office Action dated Jun. 28, 2005. |
U.S. Appl. No. 10/836,492, filed Apr. 30, 2004 Final Office Action dated Nov. 23, 2005. |
U.S. Appl. No. 10/836,492, filed Apr. 30, 2004 Non-Final Office Action dated Jun. 8, 2005. |
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Final Office Action dated Apr. 28, 2008. |
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Final Office Action dated Jun. 3, 2009. |
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Non-Final Office Action dated Dec. 18, 2007. |
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Non-Final Office Action dated Oct. 2, 2008. |
U.S. Appl. No. 10/873,514, filed Jun. 21, 2004 Non-Final Office Action dated Jan. 23, 2007. |
U.S. Appl. No. 11/429,849, filed May 8, 2006 Final Office Action mailed Mar. 11, 2009. |
U.S. Appl. No. 11/429,849, filed May 8, 2006 Final Office Action mailed Oct. 15, 2008. |
U.S. Appl. No. 11/447,626, filed Jun. 6, 2006 Final Office Action dated Nov. 14, 2008. |
U.S. Appl. No. 11/447,626, filed Jun. 6, 2006 Non-Final Office Action dated Apr. 16, 2008. |
U.S. Appl. No. 11/447,626, filed Jun. 6, 2006 Non-Final Office Action dated Sep. 13, 2007. |
U.S. Appl. No. 12/272,411, filed Nov. 17, 2008 Final Office Action dated Mar. 9, 2011. |
U.S. Appl. No. 12/272,411, filed Nov. 17, 2009 Non-Final Office Action dated Oct. 4, 2010. |
U.S. Appl. No. 12/538,361, filed Aug. 10, 2009 Final Office Action dated Sep. 10, 2010. |
U.S. Appl. No. 12/538,361, filed Aug. 10, 2009 Non-Final Office Action dated May 26, 2010. |
U.S. Appl. No. 12/538,361, filed Aug. 10, 2009 Notice of Allowance dated Dec. 2, 2010. |
U.S. Appl. No. 12/546,483, filed Aug. 24, 2009 Final Office Action dated Oct. 20, 2011. |
U.S. Appl. No. 12/546,483, filed Aug. 24, 2009 Non-Final Office Action dated Jun. 23, 2011. |
U.S. Appl. No. 13/023,403, filed Feb. 8, 2011 Non-Final Office Action dated Apr. 27, 2012. |
U.S. Appl. No. 13/023,403, filed Feb. 8, 2011 Non-Final Office Action dated Nov. 23, 2012. |
U.S. Appl. No. 13/088,129, filed Apr. 15, 2011 Non-Final Office Action dated Jun. 29, 2011. |
U.S. Appl. No. 13/434,472, filed Mar. 29, 2012 Non-Final Office Action dated Jun. 8, 2012. |
U.S. Appl. No. 13/434,472, filed Mar. 29, 2012 Notice of Allowance dated Sep. 20, 2012. |
Villani, V., “A Study on the Thermal Behaviour and Structural Characteristics of Polytetrafluoroethylene,” Thermochimica Acta, 162:189-193 (1990). |
Number | Date | Country | |
---|---|---|---|
20130102839 A1 | Apr 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09855918 | May 2001 | US |
Child | 10431685 | US | |
Parent | 08999583 | Dec 1997 | US |
Child | 09855918 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13434472 | Mar 2012 | US |
Child | 13715874 | US | |
Parent | 12546483 | Aug 2009 | US |
Child | 13434472 | US | |
Parent | 11429849 | May 2006 | US |
Child | 12546483 | US | |
Parent | 10431685 | May 2003 | US |
Child | 11429849 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US95/16497 | Dec 1995 | US |
Child | 08999583 | US | |
Parent | 08794871 | Feb 1997 | US |
Child | PCT/US95/16497 | US | |
Parent | 08833797 | Apr 1997 | US |
Child | 08794871 | US | |
Parent | 08508033 | Jul 1995 | US |
Child | 08833797 | US | |
Parent | 08401871 | Mar 1995 | US |
Child | 08508033 | US |